InflaRx NV (IFRX)
1.34
-0.07
(-4.96%)
USD |
NASDAQ |
May 02, 11:46
InflaRx Shareholders Equity (Quarterly): 113.39M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 113.39M |
| September 30, 2023 | 124.89M |
| June 30, 2023 | 135.46M |
| March 31, 2023 | 85.69M |
| December 31, 2022 | 94.75M |
| September 30, 2022 | 97.74M |
| June 30, 2022 | 106.69M |
| March 31, 2022 | 106.16M |
| December 31, 2021 | 119.20M |
| September 30, 2021 | 133.65M |
| June 30, 2021 | 147.10M |
| March 31, 2021 | 162.77M |
| December 31, 2020 | 95.77M |
| September 30, 2020 | 105.31M |
| Date | Value |
|---|---|
| June 30, 2020 | 102.48M |
| March 31, 2020 | 111.98M |
| December 31, 2019 | 120.02M |
| September 30, 2019 | 134.74M |
| June 30, 2019 | 148.80M |
| March 31, 2019 | 163.92M |
| December 31, 2018 | 173.18M |
| September 30, 2018 | 184.25M |
| June 30, 2018 | 187.05M |
| March 31, 2018 | 138.13M |
| December 31, 2017 | 143.28M |
| September 30, 2017 | -42.59M |
| June 30, 2017 | -37.38M |
| December 31, 2016 | -27.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
85.69M
Minimum
Mar 2023
162.77M
Maximum
Mar 2021
118.24M
Average
113.39M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 63.90M |
| MorphoSys AG | 54.22M |
| BioNTech SE | 22.38B |
| Immatics NV | 248.81M |
| CureVac NV | 571.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.88M |
| Total Liabilities (Quarterly) | 19.48M |
| Current Ratio | 6.499 |